Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureRachel Angelica Mariani, Jyotinder Nain Punia, Marimar de la Cruz Bonilla, Pichayut Nithagon, Metin Ozdemirli, Wen Shuai, Larry Wang, Oussama Abla, Shunyou Gong
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Unresolved referenced work
2017
The International Consensus classification of mature lymphoid neoplasms: a report from the Clinical Advisory Committee
10.1182/blood.2022015851 · 2022
The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms
10.1038/s41375-022-01620-2 · 2022
Diagnosis and management of post-transplant lymphoproliferative disease following solid organ transplantation in children, adolescents, and young adults
10.1016/j.beha.2023.101446 · 2023
Clinicopathologic spectrum of pediatric posttransplant lymphoproliferative diseases following solid organ transplant
10.5858/arpa.2023-0323-ra · 2024
Post-transplant lymphoproliferative disease in pediatric solid organ transplant recipients
10.3109/08880018.2013.798844 · 2013
T-cell post-transplantation lymphoproliferative disorders after cardiac transplantation: a single institutional experience
10.1111/j.1365-2141.2004.05212.x · 2004
Clinicopathological characteristics of posttransplant lymphoproliferative disorders of T-cell origin: single-center series of nine cases and meta-analysis of 147 reported cases
10.3109/10428194.2013.775436 · 2013
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
Pediatric T-cell post-transplant lymphoproliferative disorder after solid organ transplantation
10.1002/pbc.21072 · 2008
Risk factors and prognosis in T-cell posttransplantation lymphoproliferative diseases: reevaluation of 163 cases
10.1097/tp.0b013e3182762e07 · 2013
T-cell and NK-cell posttransplantation lymphoproliferative disorders
10.1309/lyxn3rgf7d7kpyg0 · 2007
Epstein-Barr virus-associated lymphomatoid papules: a sign of immunosuppression resembling lymphomatoid papulosis
10.1097/dad.0000000000002479 · 2023
Primary cutaneous posttransplant lymphoproliferative disorders in solid organ transplant recipients: a multicenter European case series
10.1111/ajt.12281 · 2013
Peripheral T-cell lymphoma in children and adolescents: a single-institution experience
10.1097/mph.0b013e3182707592 · 2012
Post transplant T-cell lymphoma: a case series of four patients from a single unit and review of the literature
10.1111/j.1600-6143.2004.00521.x · 2004
Late-onset peripheral T-cell lymphoma not otherwise specified in a liver transplant recipient: a rare subtype of posttransplant lymphoproliferative disorder
10.1016/j.jceh.2020.09.002 · 2021
Successful use of alemtuzumab in a child with refractory peripheral T-cell posttransplant lymphoproliferative disorder
10.1097/mph.0b013e318182e799 · 2008
Genomic profiling for clinical decision making in lymphoid neoplasms
10.1182/blood.2022015854 · 2022
Genetic landscape of T- and NK-cell post-transplant lymphoproliferative disorders
10.18632/oncotarget.9400 · 2016
Characteristics and outcome of post-transplant lymphoproliferative disorders after solid organ transplantation: a single center experience of 196 patients over 30 years
10.3389/ti.2022.10707 · 2022
Treatment of monomorphic posttransplant lymphoproliferative disorder in pediatric solid organ transplant: a multicenter review
10.1097/mph.0000000000002804 · 2024
CD30 expression in pediatric neoplasms, study of 585 cases
10.1177/1093526616689185 · 2017
Brentuximab vedotin use in pediatric anaplastic large cell lymphoma
10.3389/fimmu.2023.1203471 · 2023
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
10.1016/s0140-6736(18)32984-2 · 2019
Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphoma
10.1002/pbc.21171 · 2008
Post-transplant indolent T cell lymphoproliferative disorder in living donor liver transplantation: a case report
10.1186/s40792-020-00904-y · 2020
No additional external references are available.